Fasciola hepatica: effect of 4-amino-6-trichloroethenyl-1,3-benzenedisulfonamide on glycolysis in vitro.
D000255:Adenosine Triphosphate / Q000096:biosynthesis; D001692:Biological Transport / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005210:Fasciola hepatica / Q000187:drug effects* / Q000378:metabolism; D005232:Fatty Acids, Volatile / Q000096:biosynthesis; D005947:Glucose / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects*; D010735:Phosphoglycerate Kinase / Q000037:antagonists & inhibitors; D010736:Phosphoglycerate Mutase / Q000037:antagonists & inhibitors; D013424:Sulfanilamides / Q000494:pharmacology*; D014241:Trichloroethylene / Q000031:analogs & derivatives / Q000494:pharmacology
D005232:Fatty Acids, Volatile; D013424:Sulfanilamides; D014241:Trichloroethylene; D000255:Adenosine Triphosphate; D010735:Phosphoglycerate Kinase; D010736:Phosphoglycerate Mutase; C015675:clorsulon; D005947:Glucose